To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC1A5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
353 supporting clones for gene SLC1A5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG394090 eye, retinoblastoma .a 1 to 791 1 to 796   tiling clone,   796/1079
(73 %)
31 diff
(97.2 %id)
BM147529 leukopheresis .a 20 to 535 1 to 518       518/518
(100 %)
8 diff
(98.5 %id)
AK292690 thymus .a 21 to 2900 1 to 2872 exact     2872/2872
(100 %)
4 diff
(99.9 %id)
BJ997034 hepatoblastoma .a 21 to 424 1 to 404       404/404
(100 %)
0 diff
(100 %id)
BP282620 bone marrow .a 21 to 602 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BU846042 ovary, teratocarcinoma, cell line .a 22 to 789 30 to 808       779/1003
(77 %)
21 diff
(98.0 %id)
BU557343 ovary, teratocarcinoma, cell line .a 23 to 827 6 to 826       821/924
(88 %)
6 diff
(99.4 %id)
BX439142 placenta .a 28 to 984 1 to 953       953/953
(100 %)
18 diff
(98.2 %id)
CN483412 eye .a 28 to 647 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BQ222967 melanotic melanoma, skin .a 28 to 839 12 to 840       829/882
(93 %)
6 diff
(99.4 %id)
AL528134 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 29 to 1010 1 to 979       979/979
(100 %)
10 diff
(99.0 %id)
BX462261 B cells (Ramos cell line) .a 29 to 688 1 to 660       660/660
(100 %)
4 diff
(99.4 %id)
BX437979 neuroblastoma .a 30 to 1176 1 to 1126       1126/1129
(99 %)
33 diff
(97.1 %id)
BX344578   .a 30 to 1052 1 to 1015       1015/1023
(99 %)
11 diff
(99.0 %id)
NM_005628.2   .a 30 to 2902 1 to 2873 exact RefSeq,   2873/2873
(100 %)
0 diff
(100 %id)
U53347   .a 30 to 2899 1 to 2867 T18P A19P N20T G22A L23W ... tiling clone, AAA   2867/2867
(100 %)
8 diff
(99.8 %id)
CN293357 embryonic stem cells, cell lines H1, H7, andH9 .a 31 to 681 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BU845563 ovary, teratocarcinoma, cell line .a 31 to 812 40 to 828       789/1015
(77 %)
18 diff
(98.3 %id)
BM809237 amelanotic melanoma, cell line, skin .a 32 to 352 1 to 325       325/1077
(30 %)
13 diff
(98.8 %id)
BU854903 ovary, teratocarcinoma, cell line .a 32 to 884 1 to 858       858/907
(94 %)
6 diff
(99.4 %id)
BX438600 neuroblastoma .a 33 to 901 1 to 868       868/868
(100 %)
2 diff
(99.8 %id)
BQ063364 lymph, lymphoma, cell line .a 35 to 872 1 to 847       847/1012
(83 %)
21 diff
(98.0 %id)
BU192568 eye, retinoblastoma .a 36 to 867 1 to 851       851/902
(94 %)
30 diff
(96.7 %id)
BF316078 brain, neuroblastoma .a 37 to 835 1 to 786   AAA   786/1082
(72 %)
30 diff
(97.3 %id)
BF311024 brain, neuroblastoma .a 37 to 801 1 to 756       756/1038
(72 %)
14 diff
(98.7 %id)
BQ877572 melanotic melanoma, cell line, skin .a 41 to 806 1 to 781       781/972
(80 %)
25 diff
(97.5 %id)
BQ892844 melanotic melanoma, cell line, skin .a 41 to 890 1 to 857       857/925
(92 %)
33 diff
(96.5 %id)
BQ682479 melanotic melanoma, cell line, skin .a 41 to 885 1 to 848       848/930
(91 %)
15 diff
(98.4 %id)
BE900925 choriocarcinoma, placenta .a 43 to 793 1 to 752       752/1083
(69 %)
15 diff
(98.7 %id)
CN293372 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 44 to 748 1 to 705       705/705
(100 %)
2 diff
(99.8 %id)
TI_44185752   .a 45 to 731 23 to 713       691/714
(96 %)
6 diff
(99.2 %id)
BG030219 breast, mammary adenocarcinoma, cell line .a 47 to 818 1 to 762       762/958
(79 %)
13 diff
(98.7 %id)
CN293390 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 50 to 797 1 to 748       748/748
(100 %)
4 diff
(99.5 %id)
CN293404 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 50 to 760 1 to 711       711/711
(100 %)
0 diff
(100 %id)
BE909918 epithelioid carcinoma, Pancreas .a 51 to 673 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
AL529820 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 56 to 1119 1 to 1051       1051/1062
(98 %)
23 diff
(97.9 %id)
CR988519 T-Lymphocytes .a 56 to 536 1 to 481       481/481
(100 %)
0 diff
(100 %id)
AF105423   .a 59 to 2900 1 to 2839 exact AAA   2839/2839
(100 %)
3 diff
(99.9 %id)
CN293399 embryonic stem cells, DMSO-treated H9 cellline .a 61 to 249 1 to 189       189/189
(100 %)
0 diff
(100 %id)
BG421272 Kidney, renal cell adenocarcinoma .a 62 to 888 1 to 813       813/904
(89 %)
30 diff
(96.7 %id)
BQ216704 melanotic melanoma, skin .a 62 to 930 1 to 875       875/877
(99 %)
13 diff
(98.6 %id)
BU931706 ovary, teratocarcinoma, cell line .a 62 to 874 1 to 817       817/902
(90 %)
11 diff
(98.8 %id)
AB209738 aorta endothelial cell .a 64 to 2397 1 to 2334 A371V V512L tiling clone,   2334/2334
(100 %)
2 diff
(100.0 %id)
CX873108 embryonic stem .a 64 to 848 1 to 785       785/785
(100 %)
1 diff
(99.9 %id)
CR983049 T-Lymphocytes .a 72 to 820 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
TI_44348031   .a 78 to 803 86 to 804       719/808
(88 %)
10 diff
(98.8 %id)
CN293364 embryonic stem cells, cell lines H1, H7, andH9 .a 87 to 620 1 to 534       534/534
(100 %)
0 diff
(100 %id)
CN293405 embryonic stem cells, cell lines H1, H7, andH9 .a 89 to 685 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BU932028 ovary, teratocarcinoma, cell line .a 176 to 867 1 to 692       692/988
(70 %)
13 diff
(98.7 %id)
TI_57198967   .a 228 to 840 23 to 627       605/627
(96 %)
6 diff
(99.1 %id)
CR983966 T-Lymphocytes .a 242 to 848 1 to 607       607/609
(99 %)
1 diff
(99.9 %id)
BG774483 choriocarcinoma, placenta .a 265 to 1059 1 to 790       790/790
(100 %)
8 diff
(99.0 %id)
BE336665 Kidney, renal cell adenocarcinoma .a 274 to 872 1 to 597       597/602
(99 %)
7 diff
(98.9 %id)
AF105230 placenta .a 277 to 2642 1 to 2367 Q44L     2367/2367
(100 %)
3 diff
(99.9 %id)
DR156006 human embryonic stem cells differentiated toan early endodermal cell type .a 419 to 1131 1 to 713       713/713
(100 %)
0 diff
(100 %id)
CN293389 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 436 to 856 1 to 421       421/421
(100 %)
0 diff
(100 %id)
CX782641 human embryonic stem cells .a 436 to 1191 1 to 756       756/756
(100 %)
0 diff
(100 %id)
BC000062 Kidney, renal cell adenocarcinoma .a 510 to 2900 1 to 2387 V512L available from MGC, AAA   2387/2387
(100 %)
3 diff
(99.9 %id)
CN484234 eye .a 553 to 1120 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BG387149 adenocarcinoma cell line, colon .a 554 to 1307 1 to 757       761/757
(100 %)
25 diff
(96.7 %id)
CN293402 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 612 to 881 1 to 270       270/270
(100 %)
0 diff
(100 %id)
AF102826   .a 629 to 2900 1 to 2270 I453V D460G V463A D508G AAA   2270/2270
(100 %)
7 diff
(99.7 %id)
TI_1948243448   .a 649 to 1407 131 to 896       766/1291
(59 %)
28 diff
(97.9 %id)
TI_1948243513   .a 649 to 1258 142 to 751       610/1161
(52 %)
11 diff
(99.1 %id)
TI_1948243611   .a 649 to 1408 125 to 888   fully sequenced,   764/888
(86 %)
21 diff
(97.7 %id)
TI_1948243673   .a 649 to 1351 118 to 830   fully sequenced,   711/828
(85 %)
22 diff
(97.4 %id)
TI_1948243774   .a 649 to 1309 124 to 783       660/1333
(49 %)
11 diff
(99.2 %id)
TI_1948243834   .a 649 to 1258 132 to 742       609/1242
(49 %)
11 diff
(99.2 %id)
TI_1948243935   .a 649 to 1402 122 to 884   fully sequenced,   763/884
(86 %)
25 diff
(97.2 %id)
TI_1948243994   .a 649 to 1305 118 to 780       663/1170
(56 %)
22 diff
(98.2 %id)
EL733216 mixed .a 650 to 1283 1 to 634       634/635
(99 %)
1 diff
(99.9 %id)
GQ919058   .a 650 to 2275 1 to 1626 exact     1626/1626
(100 %)
1 diff
(100.0 %id)
BE616976 adenocarcinoma, colon .a 655 to 1422 1 to 766       766/832
(92 %)
27 diff
(96.8 %id)
BM455178 lymph, lymphoma, cell line .a 669 to 1462 38 to 833       796/1208
(65 %)
16 diff
(98.7 %id)
BM153435 leukopheresis .a 672 to 875 1 to 204       204/253
(80 %)
17 diff
(93.3 %id)
BE732538 choriocarcinoma, placenta .a 690 to 1473 1 to 791       791/820
(96 %)
24 diff
(97.1 %id)
CN293365 embryonic stem cells, cell lines H1, H7, andH9 .a 691 to 1150 1 to 460       460/460
(100 %)
0 diff
(100 %id)
BU858246 adenocarcinoma, cell line, breast .a 809 to 1553 1 to 750       750/868
(86 %)
16 diff
(98.2 %id)
DA753582   .a 843 to 1305 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
BM917025 blood, natural killer cells, cell line .a 862 to 1712 1 to 856       856/1127
(75 %)
15 diff
(98.7 %id)
BE614911 adenocarcinoma, Pancreas .a 884 to 1525 1 to 643       643/649
(99 %)
3 diff
(99.6 %id)
BE273445 Kidney, renal cell adenocarcinoma .a 886 to 1712 1 to 819       819/822
(99 %)
22 diff
(97.4 %id)
BE513318 Burkitt lymphoma, lymph .a 886 to 1379 1 to 494       494/494
(100 %)
0 diff
(100 %id)
CN293384 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 891 to 1647 1 to 758       758/758
(100 %)
1 diff
(99.9 %id)
BQ681659 melanotic melanoma, cell line, skin .a 898 to 1665 20 to 788       769/959
(80 %)
32 diff
(96.7 %id)
BQ680859 melanotic melanoma, cell line, skin .a 899 to 1198 1 to 300       300/300
(100 %)
0 diff
(100 %id)
BE902621 choriocarcinoma, placenta .a 923 to 1713 1 to 778       778/946
(82 %)
20 diff
(97.9 %id)
BM917256 blood, natural killer cells, cell line .a 934 to 1600 1 to 668       668/1101
(60 %)
14 diff
(98.8 %id)
BX360265 Placenta Cot 25-normalized .a 960 to 1904 1 to 943       943/1023
(92 %)
4 diff
(99.7 %id)
CR994519 T-Lymphocytes .a 1021 to 1815 1 to 798       798/800
(99 %)
4 diff
(99.5 %id)
TI_57230751   .a 1091 to 1799 55 to 764       710/712
(99 %)
2 diff
(99.8 %id)
BI871612 adenocarcinoma, cell line, Liver .a 1092 to 1799 1 to 709       709/711
(99 %)
2 diff
(99.8 %id)
BM918247 blood, natural killer cells, cell line .a 1103 to 1903 1 to 801       801/1072
(74 %)
4 diff
(99.7 %id)
TI_154197786   .a 1147 to 2032 49 to 934       886/1106
(80 %)
32 diff
(97.2 %id)
BE531331 adenocarcinoma, Pancreas .a 1155 to 1901 1 to 749       749/851
(88 %)
10 diff
(98.9 %id)
BU957488 adenocarcinoma, cell line, breast .a 1159 to 1931 1 to 776       776/924
(83 %)
5 diff
(99.5 %id)
DA892082 rectum .a 1161 to 1702 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA977610 synovial membrane tissue from rheumatioidarthritis .a 1161 to 1727 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BQ670238 epidermoid carcinoma, cell line, salivary gland .a 1164 to 1946 1 to 795       795/872
(91 %)
14 diff
(98.4 %id)
CA488066   .a 1180 to 2009 1 to 843       843/936
(90 %)
22 diff
(97.7 %id)
BP207903 coronary artery .a 1199 to 1780 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_154196154   .a 1200 to 2033 45 to 872       828/1050
(78 %)
14 diff
(98.7 %id)
BE866878 adenocarcinoma, colon .a 1210 to 1788 1 to 579       579/579
(100 %)
0 diff
(100 %id)
TI_59382620   .a 1211 to 1903 97 to 796       700/914
(76 %)
11 diff
(98.8 %id)
BG823389 adenocarcinoma cell line, colon .a 1216 to 2037 3 to 821       821/875
(93 %)
21 diff
(97.6 %id)
BU164945 eye, retinoblastoma .a 1216 to 2012 1 to 802       802/876
(91 %)
28 diff
(96.9 %id)
BF380362 uterus_tumor .a 1222 to 1477 256 to 1       256/256
(100 %)
0 diff
(100 %id)
BM739175 Ascites, stomach .a 1235 to 1824 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BM743723 Ascites, stomach .a 1235 to 1839 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BM765136 Ascites, stomach .a 1235 to 1759 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BM773147 Ascites, stomach .a 1235 to 1639 1 to 405       405/405
(100 %)
0 diff
(100 %id)
BM772638 Ascites, stomach .a 1235 to 1919 1 to 685       685/685
(100 %)
0 diff
(100 %id)
BM781746 Ascites, stomach .a 1235 to 1932 1 to 698       698/698
(100 %)
0 diff
(100 %id)
BG824750 adenocarcinoma cell line, colon .a 1237 to 2126 1 to 889       889/895
(99 %)
20 diff
(97.8 %id)
BM784210 stomach .a 1242 to 1948 1 to 707       707/707
(100 %)
0 diff
(100 %id)
BM784239 stomach .a 1242 to 1908 1 to 667       667/667
(100 %)
0 diff
(100 %id)
BM785039 stomach .a 1242 to 1697 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BM772438 stomach .a 1242 to 1908 1 to 667       667/667
(100 %)
0 diff
(100 %id)
DA037187   .a 1243 to 2020 2 to 777   capped   776/779
(99 %)
15 diff
(98.1 %id)
CN293378 embryonic stem cells, cell lines H1, H7, andH9 .a 1246 to 1947 1 to 702       702/702
(100 %)
0 diff
(100 %id)
BQ962681 leiomyosarcoma, uterus .a 1249 to 2042 1 to 798       798/898
(88 %)
8 diff
(99.2 %id)
BE397340 Burkitt lymphoma, lymph .a 1252 to 1792 1 to 541       541/541
(100 %)
0 diff
(100 %id)
BU147207 brain, neuroblastoma, cell line .a 1259 to 2039 14 to 798       785/951
(82 %)
15 diff
(98.5 %id)
BU854946 ovary, teratocarcinoma, cell line .a 1259 to 2032 53 to 844       792/1001
(79 %)
28 diff
(97.3 %id)
BM468862 duodenal adenocarcinoma, cell line, small intestine .a 1264 to 2033 1 to 777       777/1003
(77 %)
16 diff
(98.5 %id)
BU956703 adenocarcinoma, cell line, breast .a 1280 to 2084 1 to 813       810/900
(90 %)
10 diff
(98.9 %id)
BQ424058 eye, retinoblastoma .a 1283 to 1945 1 to 665       665/899
(73 %)
3 diff
(99.7 %id)
CV805383 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1300 to 2037 1 to 738       738/888
(83 %)
10 diff
(98.9 %id)
TI_1948243995   .a 1305 to 2274 1095 to 127       969/1354
(71 %)
25 diff
(98.2 %id)
BU168366 adenocarcinoma, Pancreas .a 1310 to 2103 1 to 796       796/929
(85 %)
15 diff
(98.4 %id)
BE563081 endometrium, adenocarcinoma cell line, uterus .a 1311 to 2180 40 to 900       859/990
(86 %)
36 diff
(96.4 %id)
TI_1948243835   .a 1311 to 2274 1069 to 127       943/1310
(71 %)
32 diff
(97.6 %id)
TI_1948243514   .a 1316 to 2274 1061 to 130       932/1226
(76 %)
34 diff
(97.3 %id)
TI_1948243674   .a 1321 to 2274 1078 to 128   fully sequenced,   951/1078
(88 %)
26 diff
(97.6 %id)
TI_1948243775   .a 1325 to 2274 1067 to 127       942/1329
(70 %)
26 diff
(98.1 %id)
AA099481 colon, tumor .a 1326 to 1707 1 to 382       382/382
(100 %)
6 diff
(98.5 %id)
BE336620 adenocarcinoma cell line, ovary .a 1329 to 1857 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BG469450 adenocarcinoma cell line, colon .a 1336 to 2167 1 to 832       832/861
(96 %)
19 diff
(97.8 %id)
BE074605 breast .a 1349 to 1583 248 to 14     Submitted on the opposite strand 235/249
(94 %)
3 diff
(98.8 %id)
BM746437 stomach .a 1366 to 1861 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BM745260 stomach .a 1366 to 1958 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BM783360 stomach .a 1366 to 2033 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BG385557 adenocarcinoma cell line, colon .a 1367 to 2176 1 to 797       797/886
(89 %)
26 diff
(97.1 %id)
TI_1948243936   .a 1372 to 2274 1021 to 127   fully sequenced,   895/1021
(87 %)
13 diff
(98.8 %id)
TI_1948243612   .a 1378 to 2274 1016 to 127   fully sequenced,   890/1016
(87 %)
10 diff
(99.1 %id)
BG472867 eye, retinoblastoma .a 1392 to 2205 1 to 817       817/819
(99 %)
15 diff
(98.2 %id)
BU596035 mixed (pool of 40 RNAs) .a 1398 to 2159 1 to 770       770/770
(100 %)
27 diff
(96.5 %id)
BE744894 adenocarcinoma cell line, ovary .a 1406 to 2174 1 to 758       758/986
(76 %)
14 diff
(98.6 %id)
BG328650 adenocarcinoma cell line, colon .a 1411 to 2110 1 to 700       700/701
(99 %)
1 diff
(99.9 %id)
BU180845 large cell carcinoma, lung .a 1449 to 2237 1 to 796       796/906
(87 %)
16 diff
(98.3 %id)
BG333262 large cell carcinoma, lung .a 1450 to 2096 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BU539759 adenocarcinoma, cell line, breast .a 1456 to 2317 1 to 866       866/895
(96 %)
20 diff
(97.8 %id)
BU956258 adenocarcinoma, cell line, breast .a 1458 to 2168 1 to 716       716/857
(83 %)
7 diff
(99.2 %id)
TI_1948243449   .a 1458 to 2274 941 to 129       813/1238
(65 %)
15 diff
(98.8 %id)
BG119244 adenocarcinoma, cell line, Liver .a 1472 to 2256 1 to 785       785/953
(82 %)
29 diff
(97.0 %id)
BQ708838 Spleen .a 1472 to 2263 1 to 797       797/928
(85 %)
16 diff
(98.3 %id)
BU552758 ovary, teratocarcinoma, cell line .a 1477 to 2349 1 to 875       875/875
(100 %)
8 diff
(99.1 %id)
AW410410 muscle, rhabdomyosarcoma .a 1486 to 2110 18 to 642       625/642
(97 %)
7 diff
(99.0 %id)
BF205540 muscle, rhabdomyosarcoma .a 1487 to 2229 1 to 749       749/849
(88 %)
30 diff
(96.5 %id)
BG437812 large cell carcinoma, lung .a 1489 to 2286 1 to 797       797/810
(98 %)
19 diff
(97.7 %id)
CK327157 breast .a 1495 to 1981 495 to 2     Submitted on the opposite strand 492/496
(99 %)
31 diff
(93.8 %id)
BE783126 eye, retinoblastoma .a 1502 to 2260 1 to 750       750/753
(99 %)
14 diff
(98.2 %id)
CD513982 brain, Pituitary .a 1513 to 2283 1 to 788       788/961
(81 %)
32 diff
(96.7 %id)
BG468450 adenocarcinoma cell line, colon .a 1517 to 2297 1 to 782       782/782
(100 %)
1 diff
(99.9 %id)
CN293369 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1524 to 1804 1 to 281       281/281
(100 %)
0 diff
(100 %id)
BQ653310 hepatocellular carcinoma, cell line, Liver .a 1525 to 2349 30 to 868       839/926
(90 %)
27 diff
(97.1 %id)
BQ654340 hepatocellular carcinoma, cell line, Liver .a 1525 to 2419 48 to 949       902/949
(95 %)
39 diff
(95.9 %id)
BQ330649 lung_tumor .a 1528 to 1903 388 to 13       376/399
(94 %)
0 diff
(100 %id)
BQ682154 melanotic melanoma, cell line, skin .a 1532 to 2306 1 to 782       782/925
(84 %)
21 diff
(97.8 %id)
W40520 Pancreas, pancreatic islet .a 1544 to 1674 131 to 1     Submitted on the opposite strand 131/250
(52 %)
0 diff
(100 %id)
BE249913 adenocarcinoma cell line, colon .a 1544 to 2374 1 to 825       825/905
(91 %)
25 diff
(97.3 %id)
BE305060 adenocarcinoma cell line, colon .a 1544 to 1977 1 to 435       435/435
(100 %)
2 diff
(99.6 %id)
BQ232093 melanotic melanoma, skin .a 1553 to 2309 1 to 759       759/841
(90 %)
3 diff
(99.7 %id)
AW841604 colon_normal .a 1557 to 1782 226 to 1       226/251
(90 %)
0 diff
(100 %id)
BG740804 skin .a 1577 to 2378 1 to 804       804/815
(98 %)
9 diff
(98.9 %id)
BU159534 eye, retinoblastoma .a 1589 to 2466 1 to 886       886/888
(99 %)
16 diff
(98.2 %id)
BF817147 colon_ins .a 1592 to 1877 289 to 4     Submitted on the opposite strand 286/289
(98 %)
0 diff
(100 %id)
BU857855 adenocarcinoma, cell line, breast .a 1593 to 2414 1 to 831       831/919
(90 %)
14 diff
(98.5 %id)
BU860489 adenocarcinoma, cell line, breast .a 1593 to 2463 1 to 876       876/890
(98 %)
9 diff
(99.0 %id)
BU541081 carcinoma, cell line, Prostate .a 1597 to 2459 1 to 869       869/906
(95 %)
12 diff
(98.7 %id)
BG280901 melanotic melanoma, skin .a 1620 to 2534 1 to 909       909/993
(91 %)
36 diff
(96.4 %id)
BQ304400 breast .a 1621 to 1836 218 to 3       216/219
(98 %)
9 diff
(95.9 %id)
BU856887 adenocarcinoma, cell line, breast .a 1623 to 2345 1 to 735       735/860
(85 %)
15 diff
(98.3 %id)
BU957296 adenocarcinoma, cell line, breast .a 1623 to 2517 1 to 899       899/915
(98 %)
15 diff
(98.4 %id)
BI200161 brain, neuroblastoma .a 1636 to 2509 48 to 914       867/963
(90 %)
24 diff
(97.6 %id)
BG403600 bladder, transitional cell papilloma, cell line .a 1638 to 2351 1 to 715       715/715
(100 %)
1 diff
(99.9 %id)
CV389740 colon_ins .a 1661 to 2125 472 to 10     Submitted on the opposite strand 463/489
(94 %)
4 diff
(99.2 %id)
BM451452 eye, retinoblastoma .a 1665 to 2517 5 to 866       862/989
(87 %)
31 diff
(96.9 %id)
BM721557 eye, fetal eye .a 1671 to 2064 1 to 394       394/394
(100 %)
0 diff
(100 %id)
CX788702 human embryonic stem cells .a 1673 to 2528 1 to 856   tiling clone,   856/856
(100 %)
0 diff
(100 %id)
BM915641 amelanotic melanoma, cell line, skin .a 1680 to 2681 16 to 1020       1005/1020
(98 %)
25 diff
(97.6 %id)
TI_151773495   .a 1702 to 2287 167 to 766       606/1026
(59 %)
31 diff
(97.0 %id)
BE746823 adenocarcinoma cell line, ovary .a 1706 to 2502 1 to 792       792/927
(85 %)
15 diff
(98.4 %id)
BE900920 choriocarcinoma, placenta .a 1709 to 2501 1 to 788       788/947
(83 %)
17 diff
(98.3 %id)
BE313327 brain, neuroblastoma .a 1732 to 2586 1 to 851       851/856
(99 %)
44 diff
(94.9 %id)
BI090513 cervix .a 1738 to 2515 1 to 782       782/782
(100 %)
15 diff
(98.1 %id)
BQ926277 large cell carcinoma, lung .a 1759 to 2648 29 to 926       898/929
(96 %)
25 diff
(97.4 %id)
BM553411 duodenal adenocarcinoma, cell line, small intestine .a 1764 to 2662 1 to 911       911/1015
(89 %)
25 diff
(97.6 %id)
CN293359 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1765 to 2517 2 to 754       753/754
(99 %)
6 diff
(99.3 %id)
BY993906   .a 1765 to 2376 9 to 621       613/621
(98 %)
6 diff
(99.1 %id)
CB143693 Liver .a 1792 to 2032 1 to 241       241/241
(100 %)
0 diff
(100 %id)
BX344577   .a 1804 to 2857 1050 to 1       1050/1050
(100 %)
32 diff
(97.0 %id)
BG777092 lung, mucoepidermoid carcinoma .a 1810 to 2622 1 to 819       819/820
(99 %)
20 diff
(97.6 %id)
ES314009 occipital scalp hair, skin .a 1811 to 1982 1 to 172       172/172
(100 %)
0 diff
(100 %id)
AL528133 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1852 to 2871 1017 to 1       1017/1021
(99 %)
18 diff
(98.3 %id)
BU163713 epidermoid carcinoma, cell line, salivary gland .a 1884 to 2638 1 to 756       756/907
(83 %)
9 diff
(99.1 %id)
AL563561 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 1891 to 2839 979 to 32       948/954
(99 %)
8 diff
(99.2 %id)
BI088973 cervix .a 1900 to 2679 6 to 782       777/784
(99 %)
24 diff
(97.0 %id)
BQ306362 breast .a 1945 to 2316 369 to 1       369/369
(100 %)
4 diff
(99.0 %id)
BQ307787 breast .a 1955 to 2486 560 to 8       553/562
(98 %)
4 diff
(99.3 %id)
BQ051234 large cell carcinoma, lung .a 2000 to 2723 1 to 729       729/1057
(68 %)
16 diff
(98.5 %id)
BG164510 hypernephroma, cell line, Kidney .a 2009 to 2719 1 to 706       706/706
(100 %)
14 diff
(98.1 %id)
BI193068 epithelioid carcinoma cell line, Pancreas .a 2010 to 2715 1 to 705       705/705
(100 %)
10 diff
(98.6 %id)
BF742832 breast .a 2015 to 2376 363 to 2     Submitted on the opposite strand 362/363
(99 %)
0 diff
(100 %id)
BM850976 stomach .a 2023 to 2352 1 to 330       330/330
(100 %)
0 diff
(100 %id)
BE907529 epithelioid carcinoma, Pancreas .a 2032 to 2769 1 to 726       726/888
(81 %)
27 diff
(97.0 %id)
BE747660 adenocarcinoma cell line, ovary .a 2038 to 2725 33 to 718       686/976
(70 %)
6 diff
(99.4 %id)
BQ053857 blood, natural killer cells, cell line .a 2038 to 2687 8 to 668       661/1203
(54 %)
21 diff
(98.3 %id)
BX435837 B cells (Ramos cell line) .a 2039 to 2898 852 to 1       852/852
(100 %)
55 diff
(93.6 %id)
BE873516 adenocarcinoma, colon .a 2049 to 2724 1 to 675       675/841
(80 %)
22 diff
(97.4 %id)
CN293368 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2060 to 2722 1 to 663       663/667
(99 %)
5 diff
(99.3 %id)
AW580793 leiomios .a 2075 to 2724 671 to 26       646/671
(96 %)
0 diff
(100 %id)
BX373690 Placenta Cot 25-normalized .a 2076 to 2895 813 to 1       813/916
(88 %)
45 diff
(95.1 %id)
BE544850 cervical carcinoma cell line, cervix .a 2106 to 2728 1 to 626       626/719
(87 %)
26 diff
(96.4 %id)
BM854047 Ascites, stomach .a 2129 to 2668 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
BF033019 adenocarcinoma, ovary .a 2132 to 2757 1 to 622       622/1127
(55 %)
9 diff
(99.3 %id)
BM789075 Ascites, stomach .a 2150 to 2728 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BM013100 brain, neuroblastoma, cell line .a 2151 to 2727 1 to 580       580/985
(58 %)
16 diff
(98.4 %id)
TI_59382344   .a 2152 to 2727 96 to 674       579/984
(58 %)
16 diff
(98.4 %id)
AA852674 Bone, Hip .a 2171 to 2364 1 to 194       194/194
(100 %)
10 diff
(94.9 %id)
BG938703 Bone, Hip .a 2171 to 2768 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
BI193329 epithelioid carcinoma cell line, Pancreas .a 2209 to 2776 1 to 564       564/567
(99 %)
6 diff
(99.0 %id)
BE074021 breast .a 2216 to 2654 442 to 4     Submitted on the opposite strand 439/443
(99 %)
0 diff
(100 %id)
CN293370 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2265 to 2729 1 to 465       465/465
(100 %)
0 diff
(100 %id)
BM826558 Ascites, stomach .a 2267 to 2716 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BF869883 lung_tumor .a 2284 to 2623 340 to 1     Submitted on the opposite strand 340/342
(99 %)
1 diff
(99.8 %id)
AW410411 muscle, rhabdomyosarcoma .a 2294 to 2900 621 to 19   AAA   603/603
(100 %)
4 diff
(99.4 %id)
AW967163   .a 2313 to 2685 1 to 373       373/375
(99 %)
1 diff
(99.8 %id)
CN293383 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2323 to 2577 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BQ645027 hepatocellular carcinoma, cell line, Liver .a 2335 to 2747 1 to 413   tiling clone,   413/925
(44 %)
1 diff
(99.9 %id)
BF915249 uterus_tumor .a 2398 to 2671 1 to 274       274/276
(99 %)
13 diff
(95.3 %id)
EC449293 Prostate .a 2404 to 2505 1 to 102       102/102
(100 %)
0 diff
(100 %id)
BF913565 uterus_tumor .a 2413 to 2673 1 to 262       262/262
(100 %)
13 diff
(95.1 %id)
BF915638 uterus_tumor .a 2413 to 2673 1 to 261       261/261
(100 %)
5 diff
(98.1 %id)
BJ997035 hepatoblastoma .a 2441 to 2864 418 to 1       418/418
(100 %)
2 diff
(99.6 %id)
BQ376908 uterus .a 2443 to 2769 11 to 332       322/332
(96 %)
6 diff
(98.2 %id)
BF916742 uterus_tumor .a 2471 to 2680 233 to 24     Submitted on the opposite strand 210/233
(90 %)
0 diff
(100 %id)
FN072348 breast carcinoma .a 2474 to 2526 1 to 53       53/54
(98 %)
2 diff
(96.3 %id)
AA098963 colon, tumor .a 2484 to 2899 417 to 1       417/417
(100 %)
3 diff
(99.3 %id)
BE208054 Kidney, renal cell adenocarcinoma .a 2574 to 2902 324 to 1       324/324
(100 %)
3 diff
(99.1 %id)
AA308071 colon .a 2707 to 2747 456 to 496       496/496
(100 %)
2 diff
(99.6 %id)
AA308363 colon .a 2709 to 2760 370 to 421       421/421
(100 %)
0 diff
(100 %id)
CX782569 human embryonic stem cells .a 2735 to 2900 201 to 34   AAA   634/634
(100 %)
9 diff
(98.6 %id)
AK055630   .b 1 to 2021 1 to 2021 C132F tiling clone, available from FLJ,   2021/2021
(100 %)
6 diff
(99.8 %id)
DA031076   .b 30 to 594 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BG470843 eye, retinoblastoma .b 79 to 642 1 to 571       571/662
(86 %)
13 diff
(98.1 %id)
BG472043 eye, retinoblastoma .b 79 to 604 1 to 531       531/795
(66 %)
9 diff
(98.9 %id)
BG474450 eye, retinoblastoma .b 79 to 711 1 to 646       646/843
(76 %)
28 diff
(96.7 %id)
BG332695 large cell carcinoma, lung .b 80 to 750 1 to 667       667/861
(77 %)
19 diff
(97.8 %id)
BG395746 eye, retinoblastoma .b 80 to 782 1 to 698       698/706
(98 %)
11 diff
(98.5 %id)
BQ956420 large cell carcinoma, lung .b 83 to 1034 1 to 955       955/960
(99 %)
17 diff
(98.3 %id)
DA384177 thalamus .b 93 to 663 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BE254646 eye, retinoblastoma .b 99 to 773 1 to 670       670/671
(99 %)
10 diff
(98.6 %id)
BF183179 large cell carcinoma, lung .b 101 to 833 1 to 727       727/799
(90 %)
18 diff
(97.8 %id)
BG332137 large cell carcinoma, lung .b 101 to 820 1 to 715       715/839
(85 %)
18 diff
(97.9 %id)
BP204547 coronary artery .b 103 to 688 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BP305950   .b 105 to 682 1 to 580       580/580
(100 %)
4 diff
(99.4 %id)
CN293394 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 112 to 628 1 to 518       518/518
(100 %)
7 diff
(98.7 %id)
DA553345   .b 117 to 674 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BM906533 ovary (pool of 3) .b 136 to 937 15 to 823       809/1069
(75 %)
24 diff
(97.8 %id)
DA602873   .b 151 to 735 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CN293393 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 317 to 902 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
BC014403 Kidney, renal cell adenocarcinoma .b 356 to 2033 1 to 1674   tiling clone, available from MGC, AAA   1674/3561
(47 %)
5 diff
(99.9 %id)
BM916938 blood, natural killer cells, cell line .b 1169 to 2031 899 to 36   AAA Submitted on the opposite strand 864/1072
(80 %)
20 diff
(98.2 %id)
CA488928   .b 1169 to 2012 14 to 857       844/897
(94 %)
36 diff
(96.0 %id)
TI_149296921   .b 1169 to 2030 933 to 79   AAA   855/942
(90 %)
9 diff
(99.1 %id)
BU539612 adenocarcinoma, cell line, breast .b 1194 to 2026 828 to 1     Submitted on the opposite strand 828/893
(92 %)
18 diff
(98.0 %id)
BU955789 adenocarcinoma, cell line, breast .b 1223 to 2014 1 to 792   tiling clone,   792/958
(82 %)
5 diff
(99.5 %id)
BM999352 Fibrosarcoma .b 1242 to 2031 804 to 19   AAA   786/786
(100 %)
6 diff
(99.3 %id)
TI_149298905   .b 1252 to 2027 864 to 90   AAA   775/968
(80 %)
17 diff
(98.3 %id)
BM999379 Fibrosarcoma .b 1256 to 2031 791 to 19   AAA   773/773
(100 %)
6 diff
(99.3 %id)
BU846123 ovary, teratocarcinoma, cell line .b 1256 to 2031 803 to 27   AAA Submitted on the opposite strand 777/977
(79 %)
13 diff
(98.7 %id)
BM982072 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1260 to 2030 787 to 19   AAA   769/769
(100 %)
2 diff
(99.8 %id)
BG179158 adenocarcinoma, cell line, Prostate .b 1268 to 1936 7 to 672       666/672
(99 %)
6 diff
(99.2 %id)
AL515305 neuroblastoma, placenta .b 1299 to 2033 840 to 108   AAA Submitted on the opposite strand 733/819
(89 %)
0 diff
(100 %id)
BU845988 ovary, teratocarcinoma, cell line .b 1324 to 2212 922 to 23   AAA Submitted on the opposite strand 900/917
(98 %)
13 diff
(98.6 %id)
BU855725 ovary, teratocarcinoma, cell line .b 1384 to 2212 853 to 23   tiling clone, AAA Submitted on the opposite strand 831/920
(90 %)
26 diff
(97.2 %id)
BG938704 Bone, Hip .b 1411 to 2002 593 to 8       586/593
(98 %)
0 diff
(100 %id)
AA534898 colon .b 1442 to 1937 32 to 523     Submitted on the opposite strand 492/523
(94 %)
6 diff
(98.9 %id)
AA534587 colon .b 1442 to 1933 32 to 518     Submitted on the opposite strand 487/520
(93 %)
6 diff
(98.9 %id)
TI_154190943   .b 1463 to 2031 50 to 615   AAA   566/566
(100 %)
3 diff
(99.5 %id)
BM005714 hepatocellular carcinoma, cell line, Liver .b 1464 to 2033 1 to 582       582/590
(98 %)
28 diff
(95.3 %id)
TI_59385655   .b 1465 to 2021 62 to 628   AAA   567/579
(97 %)
26 diff
(95.6 %id)
BQ644252 hepatocellular carcinoma, cell line, Liver .b 1466 to 2031 1 to 566   AAA   566/566
(100 %)
0 diff
(100 %id)
TI_149308694   .b 1466 to 2031 648 to 89   AAA   560/935
(59 %)
6 diff
(99.4 %id)
BE504576 carcinoid, lung .b 1551 to 2030 481 to 1       481/481
(100 %)
3 diff
(99.4 %id)
BY995712   .b 1576 to 2030 1 to 449       449/449
(100 %)
5 diff
(98.9 %id)
AW054876 colon .b 1583 to 2032 451 to 1       451/451
(100 %)
3 diff
(99.4 %id)
AI095478 uterus .b 1588 to 2030 443 to 1       443/443
(100 %)
0 diff
(100 %id)
BG941279 blood .b 1632 to 1915 1 to 278       278/278
(100 %)
4 diff
(98.6 %id)
BG260093 bladder, transitional cell papilloma, cell line .b 1640 to 2031 1 to 393   AAA   393/393
(100 %)
4 diff
(99.0 %id)
AA852675 Bone, Hip .b 1704 to 2002 301 to 8       294/301
(97 %)
0 diff
(100 %id)
AA362311   .b 1757 to 2025 267 to 1     Submitted on the opposite strand 267/267
(100 %)
1 diff
(99.7 %id)
T18450   .b 1765 to 1933 1 to 165     Submitted on the opposite strand 165/165
(100 %)
4 diff
(97.6 %id)
AA605241 adrenal adenoma, adrenal gland .b 1796 to 2031 236 to 1       236/236
(100 %)
0 diff
(100 %id)
AA612586 Prostate, prostate tumor .b 1834 to 2031 198 to 1       208/208
(100 %)
0 diff
(100 %id)
AW843368 colon_normal .b 1835 to 1931 106 to 10       97/107
(90 %)
0 diff
(100 %id)
CN293374 embryonic stem cells, cell lines H1, H7, andH9 .b 1838 to 1957 122 to 1     Submitted on the opposite strand 164/164
(100 %)
3 diff
(98.2 %id)
BF206542 brain, neuroblastoma .b 1838 to 1966 528 to 653       653/926
(70 %)
21 diff
(97.8 %id)
TI_59390528   .b 1838 to 2033 332 to 529   AAA   421/961
(43 %)
2 diff
(99.8 %id)
BI823386 pooled brain, lung, testis .b 1840 to 2013 301 to 478       478/934
(51 %)
11 diff
(98.9 %id)
TI_57202738   .b 1840 to 2013 334 to 511       478/967
(49 %)
16 diff
(98.4 %id)
TI_57227806   .b 1852 to 2031 25 to 203   AAA   179/179
(100 %)
1 diff
(99.5 %id)
FN063781 breast carcinoma .b 1864 to 1958 1 to 94       94/94
(100 %)
1 diff
(99.0 %id)
BF221562 Prostate .b 1866 to 2031 181 to 16   AAA   166/166
(100 %)
0 diff
(100 %id)
NM_001145145.1   .c 1 to 1926 2 to 1927 exact RefSeq,   1927/1927
(100 %)
0 diff
(100 %id)
AK299137   .c 53 to 1924 1 to 1867 V310L tiling clone,   1867/1867
(100 %)
6 diff
(99.7 %id)
AK316546   .c 87 to 1455 1 to 1369 V139A tiling clone,   1369/1369
(100 %)
4 diff
(99.8 %id)
BP256212 Kidney .d 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
AK301661 esophagus, tumor tissue .d 55 to 1472 1 to 1418 exact     1418/1418
(100 %)
0 diff
(100 %id)
NM_001145144.1   .d 55 to 1791 1 to 1737 exact RefSeq,   1737/1737
(100 %)
0 diff
(100 %id)
DC394041 esophageal, tumor tissue .d 55 to 635 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC367132   .d 57 to 600 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
AK293433   .d 58 to 1649 1 to 1588 V284L     1588/1588
(100 %)
4 diff
(99.8 %id)
DC301904   .d 58 to 607 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BP203257 coronary artery .d 58 to 632 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
AU121957 mammary gland .d 59 to 811 2 to 759   capped   758/759
(99 %)
7 diff
(99.1 %id)
BX459015 placenta .d 60 to 1096 1 to 1030       1030/1043
(98 %)
16 diff
(98.5 %id)
AU133774 ovary, tumor tissue .d 60 to 695 2 to 635   capped   636/634
(100 %)
8 diff
(98.8 %id)
DC297135 cord Blood .d 61 to 755 1 to 695       695/697
(99 %)
6 diff
(99.2 %id)
CR618074 Placenta Cot 25-normalized .d 66 to 1750 1 to 1685 exact tiling clone,   1685/1685
(100 %)
0 diff
(100 %id)
AL545741 placenta, Placenta Cot 25-normalized .d 66 to 822 1 to 758   fully sequenced,   758/758
(100 %)
3 diff
(99.7 %id)
DR761584 embryonic stem .d 66 to 924 1 to 859       859/859
(100 %)
6 diff
(99.4 %id)
BI197576 brain, neuroblastoma .d 71 to 664 1 to 600       600/661
(90 %)
21 diff
(96.9 %id)
BI198903 brain, neuroblastoma .d 71 to 642 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
BQ957815 large cell carcinoma, lung .d 71 to 988 25 to 949       925/949
(97 %)
14 diff
(98.6 %id)
TI_57235505   .d 72 to 717 25 to 670       646/670
(96 %)
9 diff
(98.7 %id)
BI908136 leukocyte .d 76 to 717 1 to 642       642/642
(100 %)
3 diff
(99.6 %id)
TI_57247522   .d 76 to 885 24 to 835       812/835
(97 %)
25 diff
(97.1 %id)
BE336692 Kidney, renal cell adenocarcinoma .d 79 to 585 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BE548292 cervical carcinoma cell line, cervix .d 80 to 785 1 to 699       699/780
(89 %)
14 diff
(98.3 %id)
BE746776 adenocarcinoma cell line, ovary .d 84 to 746 1 to 656       656/978
(67 %)
24 diff
(97.6 %id)
BG823502 adenocarcinoma cell line, colon .d 86 to 785 1 to 697       697/698
(99 %)
15 diff
(97.9 %id)
BE781342 eye, retinoblastoma .d 87 to 788 1 to 716       716/1021
(70 %)
42 diff
(95.9 %id)
BI912436 leukocyte .d 88 to 885 1 to 801       801/801
(100 %)
14 diff
(98.3 %id)
AL521908 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 96 to 982 1 to 888       888/888
(100 %)
1 diff
(99.9 %id)
AL571350 placenta, Placenta Cot 25-normalized .d 761 to 1750 978 to 1   fully sequenced,   978/978
(100 %)
19 diff
(98.1 %id)
AU154978 ovary, tumor tissue .d 1232 to 1789 555 to 2       554/558
(99 %)
0 diff
(100 %id)
AU147682 mammary gland .d 1237 to 1789 547 to 1   tiling clone,   547/548
(99 %)
7 diff
(98.8 %id)
AL562038 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1243 to 1751 504 to 1       667/936
(71 %)
43 diff
(95.5 %id)
BE208096 Kidney, renal cell adenocarcinoma .d 1316 to 1786 471 to 4   tiling clone,   468/471
(99 %)
0 diff
(100 %id)
BF795327 lymph, lymphoma, cell line .e 1 to 746 1 to 742 V58* tiling clone,   742/932
(79 %)
11 diff
(98.9 %id)
BG284921 adenocarcinoma, cell line, Prostate .f 1 to 557 12 to 567 P9R V34* tiling clone,   556/568
(97 %)
10 diff
(98.3 %id)
BF818469 colon_ins .g-u 1 to 429 429 to 1 exact tiling clone, Submitted on the opposite strand 429/429
(100 %)
3 diff
(99.4 %id)
BF764029 colon_est .g-u 80 to 454 1 to 372 C56* tiling clone,   372/372
(100 %)
6 diff
(98.4 %id)
BM829066 Ascites, stomach .h 1 to 276 1 to 276 exact tiling clone,   276/276
(100 %)
0 diff
(100 %id)
AF334818   Gene SLC1A5, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
AK125222   Gene SLC1A5, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BF873042 lung_tumor Gene SLC1A5, variant not shown         Submitted on the opposite strand    
AL526674 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene SLC1A5, variant not shown         This clone was ignored    
AL526708 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene SLC1A5, variant not shown         This clone was ignored    
AI003710 pineal gland Gene SLC1A5, variant not shown       AAA This clone was ignored    
AA580366 colon, colon tumor Gene SLC1A5, variant not shown       AAA This clone was ignored    
AI801071 poorly differentiated adenocarcinoma withsignet ring cell features, stomach Gene SLC1A5, variant not shown         This clone was ignored    
BE207598 adenocarcinoma cell line, ovary Gene SLC1A5, variant not shown         This clone was ignored    
BE208366 adenocarcinoma cell line, ovary Gene SLC1A5, variant not shown         This clone was ignored    
AW778797 colon, moderately-differentiated adenocarcinoma Gene SLC1A5, variant not shown         This clone was ignored    
BE855654 brain, glioblastoma (pooled) Gene SLC1A5, variant not shown         This clone was ignored    
BI962945 Islets of Langerhans, Pancreas Gene SLC1A5, variant not shown         This clone was ignored    
BI966774 Islets of Langerhans, Pancreas Gene SLC1A5, variant not shown       AAA This clone was ignored    
BU538913 adenocarcinoma, cell line, breast Gene SLC1A5, variant not shown         Suspected internal deletion, this clone was ignored    
BU552793 ovary, teratocarcinoma, cell line Gene SLC1A5, variant not shown       AAA Submitted on the opposite strand    
TI_149297857   Gene SLC1A5, variant not shown       AAA This clone was ignored    
TI_154093107   Gene SLC1A5, variant not shown       AAA This clone was ignored    
CB241794 Human Lung Epithelial cells, lung Gene SLC1A5, variant not shown       AAA This clone was ignored    
BM709319 eye, optic nerve Gene SLC1A5, variant not shown       fully sequenced, This clone was ignored    
BU732468 eye, optic nerve Gene SLC1A5, variant not shown       fully sequenced, AAA This clone was ignored    
BQ574646 Chondrosarcoma Grade II, Left Pelvis Gene SLC1A5, variant not shown       AAA This clone was ignored    
CA308034 Alveolar Macrophage, lung Gene SLC1A5, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI